Oncolytics Biotech Inc (ONC) — Cash Flow Reinvestment Rate
Latest as of June 2018:
0.06x
Oncolytics Biotech Inc (ONC) has a Cash Flow Reinvestment Rate of 0.06x as of June 2018, reinvesting CA$37.44K (capex CA$37.44K ) from operating cash flow of CA$589.26K. Explore ONC capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.06x
(Capex + Investments) / Operating CF
Total Reinvested
CA$37.44K
Capex + Investments
Operating Cash Flow
CA$589.26K
CAD
Capital Expenditures
CA$37.44K
CAD
Annual Cash Flow Reinvestment Rate for Oncolytics Biotech Inc (None–None)
Year-by-year capital reinvestment analysis for Oncolytics Biotech Inc. For live market cap and broader valuation context, see market cap of Oncolytics Biotech Inc.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow